The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Acerta Pharma/AstraZeneca; BeiGene; Janssen-Cilag; LOXO; Merck; TG Therapeutics

First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.
 
John C. Byrd
Honoraria - AstraZeneca; Novartis; Novartis; Pharmacyclics; Syndax; Trillium Therapeutics
Consulting or Advisory Role - Acerta Pharma; Genentech; Jazz Pharmaceuticals; Pharmacyclics
Research Funding - Acerta Pharma (Inst); Pharmacyclics (Inst)
 
Peter Hillmen
Honoraria - Abbvie; Janssen; Roche
Research Funding - Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; Janssen
 
Paolo Ghia
Honoraria - Abbvie; ArQule; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Juno/Celgene/Bristol-Myers Squibb; Loxo/Lilly
Consulting or Advisory Role - Abbvie; ArQule; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Juno/Celgene/Bristol-Myers Squibb; Loxo/Lilly
Research Funding - Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); Novartis (Inst); Sunesis Pharmaceuticals (Inst)
 
Arnon P. Kater
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Bristol-Myers Squibb/Celgene; Janssen Oncology; lava therapeutics
Research Funding - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Janssen Oncology; Roche/Genentech
Travel, Accommodations, Expenses - Acerta Pharma/AstraZeneca; Roche/Genentech; Roche/Genentech
 
Asher Alban Akmal Chanan-Khan
Stock and Other Ownership Interests - Matthew & Asher Inc.; NanoDev Therapeutics
Honoraria - BeiGene
Research Funding - Ascentage Pharma
Patents, Royalties, Other Intellectual Property - Patent on PSMB9 biomarker
 
Richard R. Furman
Honoraria - AstraZeneca; Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; Beigene; Genentech/Roche; Incyte; Janssen Biotech; Loxo; MorphoSys; OncoTracker; Pharmacyclics; Sanofi; TG Therapeutics; Verastem
Research Funding - Acerta Pharma; TG Therapeutics
Expert Testimony - Abbvie; Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology; TG Therapeutics
Other Relationship - Incyte; Janssen Biotech
 
Susan M. O'Brien
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Autolus; Bristol-Myers Squibb; Celgene; Eisai; Gilead Sciences; GlaxoSmithKline; Janssen; Johnson & Johnson; Juno Therapeutics; Merck; Pharmacyclics; Vaniam Group; Verastem; Vida Ventures
Research Funding - Acerta Pharma (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Mustafa Nuri Yenerel
Honoraria - Johnson & Johnson; Pfizer
Travel, Accommodations, Expenses - Johnson & Johnson
 
Árpád Illés
Consulting or Advisory Role - Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Seattle Genetics; Takeda
Travel, Accommodations, Expenses - Janssen; Novartis; Pfizer; Roche
 
Neil E. Kay
Consulting or Advisory Role - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CytomX Therapeutics (Inst); DAVA Pharmaceuticals (Inst); Genentech/Abbvie (Inst); Janssen Biotech (Inst); Juno Therapeutics (Inst); MEI Pharma (Inst); MorphoSys (Inst); Oncotracker (Inst); Pharmacyclics (Inst); Rigel (Inst); Sunesis Pharmaceuticals (Inst); Targeted Oncology (Inst); TG Therapeutics (Inst); Tolero Pharmaceuticals (Inst)
Research Funding - Abbvie; Acerta Pharma; Bristol-Myers Squibb; Celgene; Genentech; MEI Pharma; Pharmacyclics/Janssen; Sunesis Pharmaceuticals; TG Therapeutics; Tolero Pharmaceuticals
 
Jose Antonio Garcia Marco
Consulting or Advisory Role - Abbvie; Janssen
Speakers' Bureau - Abbvie; Janssen; Roche
Research Funding - Janssen (Inst)
 
Anthony R. Mato
Consulting or Advisory Role - Abbvie/Genentech; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; Bristol-Myers Squibb/Pfizer; Celgene; Curio/Vaniam Group; DTRM; Johnson & Johnson; Loxo/Lilly; Merck; Pharmacyclics; TG Therapeutics; Verastem
Research Funding - Abbvie/Genentech; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; DTRM; Genmab; Johnson & Johnson; LOXO; Nurix; Pharmacyclics; Regeneron; Sunesis Pharmaceuticals; TG Therapeutics
 
John Francis Seymour
Honoraria - Abbvie; Acerta Pharma; Janssen; Roche; Sunesis Pharmaceuticals; Takeda
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; BMS; Gilead Sciences; Janssen; MEI Pharma; MorphoSys; Roche; Sunesis Pharmaceuticals; Takeda
Speakers' Bureau - Abbvie; Roche
Research Funding - Abbvie; Celgene; Janssen; Roche
Expert Testimony - Roche
Travel, Accommodations, Expenses - Abbvie; Roche
 
Stephane Leprêtre
No Relationships to Disclose
 
Stephan Stilgenbauer
Honoraria - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Speakers' Bureau - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Research Funding - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
 
Tadeusz Robak
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie; Abbvie
Research Funding - Abbvie/Genentech (Inst)
 
Priti Patel
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Kara Higgins
Employment - AstraZeneca; PROMETRIKA
 
Sophia Sohoni
Employment - AstraZeneca
Stock and Other Ownership Interests - Theravance
 
Wojciech Jurczak
No Relationships to Disclose